As of June 12, 2025, Pluristem Therapeutics Inc (PSTI) reports a Graham Number of 7.83.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Pluristem Therapeutics Inc's Graham Number to Peers
To better understand Pluristem Therapeutics Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Pluristem Therapeutics Inc (PSTI) | 7.83 |
| X4 Pharmaceuticals Inc (XFOR) | 14.99 |
| Celcuity Inc (CELC) | 14.34 |
| Enlivex Therapeutics Ltd (ENLV) | 9.06 |
| Urogen Pharma Ltd (URGN) | 6.39 |
| Evaxion Biotech A/S (EVAX) | 5.77 |
Compared to its competitors, Pluristem Therapeutics Inc's Graham Number is among the highest compared to peers, suggesting potentially stronger fundamental value according to Graham's principles.